Norepinephrine and Its Metabolites in Cerebrospinal Fluid, Plasma, and Urine: Relationship to Hypothalamic-Pituitary-Adrenal Axis Function in Depression

Archives of General Psychiatry

Volumn 45, Issue 9, 1988, Pages 849-857

  Roy, Alec ^a   Pickar, David ^a   Jong, Judith ^c   Karoum, Farouk ^b   Linnoila, Markku ^c  

^a Bethesda Neuroscience Clinic   (United States)

^b Adult Psychiatry Branch ^*  (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; HYDROCORTISONE; NORADRENALIN; VANILMANDELIC ACID;

ADULT; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DEPRESSION; HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

ADULT; DEPRESSIVE DISORDER; DEXAMETHASONE; FEMALE; HUMAN; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGE; NOREPINEPHRINE; NORMETANEPHRINE; PITUITARY-ADRENAL SYSTEM; VANILMANDELIC ACID;

EID: 0023710980     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1988.01800330081010     Document Type: Article

References (63)

1. Post R, Jimerson D, Ballenger J, Lake R, Uhde T, Goodwin F: Cerebrospinal fluid norepinephrine and its metabolites in manic-depressive illness, in Post R, Ballenger J (eds): Neurobiology of Mood Disorders. Baltimore, Williams & Wilkins, 1984, pp 539-553.
2. Siever L, Davis K: Overview: Toward a dysregulation hypothesis of depression. Am J Psychiatry 1985;142:1017-1031.
3. Carroll B, Feinberg M, Greden J, Tarika J, Albala A, Haskett R, James N, Kronfol Z, Lohr N, Steiner M, De Vigne J, Young E: A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility. Arch Gen Psychiatry 1981;38:15-22.
4. Schatzberg A, Rothschild A, Langlais P, Lerbinger J, Schildkraut J, Cole J: Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms. Psychiatry Res 1987;20:155-164.
5. Stokes P, Maas J, Davis J, Koslow S, Casper R, Stoll P: Biogenic amine and metabolite levels in depressed patients with high vs normal hypothalamic-pituitary-adrenocortical activity. Am J Psychiatry 1987;144:868-872.
6. Roy A, Pickar D, Linnoila M, Potter W: Plasma norepinephrine in affective disorders: Relationship to melancholia. Arch Gen Psychiatry 1985;42:1181-1185.
7. Roy A, Jimerson D, Pickar D: Plasma 3-methoxy-4-hydroxyphenylethyleneglycol in depressive disorders. Am J Psychiatry 1986;143:846-885.
8. Jimerson DC, Insel TR, Reus VI, Kopin IJ: Increased plasma MHPG in dexamethasone-resistant depressed patients. Arch Gen Psychiatry 1983;40:173-176.
9. Rubin L, Price L, Charney D, Heninger G: Noradrenergic function and the cortisol response to dexamethasone in depression. Psychiatry Res 1985;15:5-15.
10. De Villiers A, Russell V, Carsters M, Aalbers C, Gagiano C, Charlton D, Taljaard J: Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in unipolar major depressive disorder. Psychiatry Res 1987;22:127-140.
11. Rosenbaum A, Maruta T, Schatzberg A, Orsulak P, Jiang N, Cole J, Schildkraut J: Towards a biochemical classification of depressive disorders: VII. Urinary-free cortisol and urinary MHPG in depression. Am J Psychiatry 1983;140:314-317.
12. Roy A, Pickar D, Linnoila M, Doran A, Ninan P, Paul S: Cerebrospinal fluid monoamine and monoamine metabolites in melancholia. Psychiatry Res 1985;15:281-292.
13. Roy A, Pickar D, Douillet P, Karoum F, Linnoila M: Urinary monoamines and monoamine metabolites in subtypes of unipolar depressive disorder and normal controls. Psychol Med 1986;16:541-546.
14. American Psychiatric Association, Committee on Nomenclature and Statistics: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, DC, American Psychiatric Association, 1980.
15. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
16. Endicott J, Spitzer R: A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1979;35:837-844.
17. Karoum F, Neff N: Quantitative gas chromatography—mass spectrometry (GC-MS) of biogenic amines: Theory and practice, in Spector S, Beck N (eds): Modern Methods in Pharmacology. New York, Alan R Liss Inc, 1982, pp 39-54.
18. Jimerson D, Markey S, Oliver J, Kopin I: Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethyleneglycol and 3,4-dihydroxyphenylethyleneglycol by gas chromatography-mass spectrometry. Biomed Mass Spectrometry 1981;8:256-259.
19. Seppala T, Scheinin M, Capone A, Linnoila M: Liquid chromatographic assay for CSF catecholamines using electrochemical detection. Acta Pharmacol Toxicol 1984;55:81-87.
20. Muscettola G, Potter WZ, Pickar D, Goodwin FK: Urinary 3-methoxy4-hydroxyphenylglycol and major affective disorders. Arch Gen Psychiatry 1984;41:337-341.
21. Roy A, Guthrie S, Pickar D, Linnoila M: Plasma norepinephrine responses to cold challenge in depressed patients and normal controls. Psychiatry Res 1987;21:161-168.
22. Roy A, Jimerson D, Linnoila M, Gold P, Pickar D: Premenopausal and postmenopausal depressed patients. Aust NZ J Psychiatry 1986;20:464-469.
23. Siever L, Uhde T, Jimerson D, Lake R, Kopin I, Murphy D: Indices of noradrenergic output in depression. Psychiatry Res 1986;19:59-73.
24. Koslow SH, Maas JW, Bowden CL, Davis JM, Hanin I, Javaid J: CSF and urinary biogenic amines and metabolites in depression and mania: A controlled, univariate analysis. Arch Gen Psychiatry 1983;40:999-1010.
25. Agren J, Mefford I, Rudorfer M, Linnoila M, Potter W: Interacting neurotransmitter systems: A non-experimental approach to the 5-HIAA HVA correlation in human CSF. Psychiatry Res 1986;20:175-193.
26. Maas J, Fawcett J, Dekirmenjian H: 3-Methoxy-4-hydroxy-phenylglycol (MHPG) excretion in depressive states: A pilot study. Arch Gen Psychiatry 1968;19:129-134.
27. Schildkraut J: Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: Preliminary findings. Am J Psychiatry 1973;35:695-698.
28. Roy A, Karoum F, Linnoila M, Pickar D: Urinary free cortisol in depressed patients and normal controls: Relationship to urinary outputs of norepinephrine and normetanephrine. Psychol Med 1988;18:93-98.
29. Barnes R, Veith R, Borson S, Verhey J, Raskind M, Hatter J: High levels of plasma catecholamines in dexamethasone-resistant depressed patients. Am J Psychiatry 1983;140:1623-1625.
30. Roy A: Cortisol nonsuppression in depression: Relationship to clinical variables. J Affective Disord, in press.
31. Asnis G, Sachar E, Halbreich U, Nathan R, Novacenko H, Ostrow L: Cortisol secretion in relation to age in major depression. Psychosom Med 1981;43:235-242.
32. Lewis D, Pfohl B, Schlechte J, Coryell W: Influence of age on the cortisol response to dexamethasone. Psychiatry Res 1984;13:213-220.
33. Halbreich U, Asnis G, Zumoff B, Nathan S, Shindledecker R: Effect of age and sex on cortisol secretion in depressives and normals. Psychiatry Res 1984;13:221-229.
34. Roy A, Linnoila M, Karoum F, Pickar D: Relative activity of metabolic pathways for norepinephrine in endogenous depression. Acta Psychiatr Scand 1986;73:624-628.
35. Gold P, Loriaux D, Roy A, Kling M, Kellner C, Post R, Pickar D, Avgerinos P, Paul S, Schulte H, Oldfield E, Cutler G, Chrousos G: The corticotropin releasing factor test: Implications for the diagnosis and pathophysiology of hypercortisolism in depression and Cushing's disease. N Engl J Med 1986;314:1330-1335.
36. Valentino R, Foote S: Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. Neuroendocrinology 1987;45:28 36.
37. Valentino R, Foote S, Aston-Jones G: Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 1983;270:363-367.
38. Al-Damluji S, Perry L, Tomlin S, Bouloux P, Grossman A, Rees L, Besser G: Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. Neuroendocrinology 1987;45:68-76.
39. Nemeroff C, Widerlov E, Bissette G, Walleus H, Karlson I, Eklund K, Kilts C, Loosen R, Vale W: Elevated concentrations of corticotropinreleasing factor—like immunoreactivity in depressed patients. Science 1984;226:1342-1343.
40. Banki C, Bissette G, Arato M, O'Connor L, Nemeroff C: CSF corticotropin-releasing factor—like immunoreactivity in depression and schizophrenia. Am J Psychiatry 1987;144:873-877.
41. Roy A, Pickar D, Paul S, Doran A, Chrousos G, Gold P: CSF corticotropin-releasing hormone in depressed patients and normal control subjects. Am J Psychiatry 1987;144:641-645.
42. Roy A, Pickar D, Linnoila M, Chrousos G, Gold P: Cerebrospinal fluid corticotropin-releasing hormone in depression: Relationship to noradrenergic function. Psychiatry Res 1987;20:229-237.
43. Axelrod J, Reisine T: Stress hormones: Their interaction and regulation. Science 1984;224:452-459.
44. O'Malley K: Isolation and characterization of the human tyrosine hydroxylase gene. Read before the 26th Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 1987.
45. Markey K, Towle A, Sze P: Glucocorticoid influence on tyrosine hydroxylase activity in mouse locus coeruleus during postnatal development. Endocrinology 1982;111:1519-1523.
46. Kelner K, Pollard H: Glucocorticoid receptors and regulation of phenylethanolamine-N-methyltransferase activity in cultured chromaffin cells. J Neurosci 1985;5:2161-2168.
47. Wolkowitz OM, Doran AR, Breier A, Roy A, Jimerson DC, Sutton ME, Golden RN, Paul SM, Pickar D: The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol: Evidence for abnormal corticosteroid-catecholamine interactions in major depression. Arch Gen Psychiatry 1987;44:782-789.
48. Paton D: The Mechanisms of Neuronal and Extraneuronal Transport of Catecholamines. New York, Raven Press, 1976, pp 95-153, 325-354.
49. Trendelenburg U: A kinetic analysis of the extraneuronal uptake and metabolism of catecholamines. Rev Physiol Biochem Pharmacol 1980;87:33-115.
50. Luchelli-Fortis M, Langer S: Selective inhibition by hydrocortisone of 3H-normetanephrine formation during 3H-transmitter release elicited by nerve stimulation in the isolated nerve-muscle preparation of the cat nictitating membrane. Naunyn Schmiedebergs Arch Pharmacol 1975;287:261-275.
51. Iversen L, Salt P: Inhibition of catecholamine uptake2 by steroids in the isolated rat heart. Br J Pharmacol 1970;40:528-530.
52. Chang P, Van der Krogt J, Van Brummelen P: Demonstration of neuronal and extraneuronal uptake of circulating norepinephrine in the forearm. Hypertension 1987;9:647-653.
53. Raskind MA, Peskind ER, Halter JB, Jimerson DC: Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease. Arch Gen Psychiatry 1983;41:343-346.
54. Hawley RJ, Major LF, Schulman EA, Linnoila M: Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal: Correlations with clinical signs. Arch Gen Psychiatry 1985;42:1056-1062.
55. Jimerson D, Rubinow D, Ballenger J, Post R, Kopin I: Cerebrospinal fluid norepinephrine metabolites in depressed patients: New methodologies, in Usdin E, Carlsson A, Dahlstrom A, Engel J (eds): Catecholamines: Neuropharmacology and Central Nervous System: Therapeutic Aspects. New York, Alan R Liss Inc, 1984, pp 123-129.
56. Kopin I, Gordon E, Jimerson D, Polinsky R: Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science 1983;219:73-75.
57. Linnoila M, Karoum F, Potter WZ: High correlation of norepinephrine and its major metabolite excretion rates. Arch Gen Psychiatry 1982;39:521-523.
58. Linnoila M, Guthrie S, Lane E, Karoum F, Rudorfer M, Potter W: Clinical studies on norepinephrine metabolism: How to interpret the numbers. Psychiatry Res 1986;17:229-239.
59. Roy A, Guthrie S, Karoum F, Pickar D, Linnoila M: High intercorrelations among urinary outputs of norepinephrine and its major metabolites: A replication in depressed patients and controls. Arch Gen Psychiatry 1988;45:158-161.
60. Ziegler M, Lake R, Wood J, Brooks B, Ebert M: Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood— cerebrospinal fluid barrier for norepinephrine. J Neurochem 1977;28:677-679.
61. Reiner P: Correlational analysis of central noradrenergic neuronal activity and sympathetic tone in behaving rats. Brain Res 1986;378:86-96.
62. Abercrombie E, Jacobs B: Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats: I. Acutely presented stressful and nonstressful stimuli. J Neurosci 1987;7:2837-2843.
63. Abercrombie E, Jacobs B: Single unit response of noradrenergic neurons in the locus coeruleus of freely moving cats: II. Adaptation to chronically presented stressful stimuli. J Neurosci 1987;7:2844-2848.